Prestigious Recognition: Dr Christof Augenstein listed in IAM Strategy 300 – The World’s Leading IP Strategists 2025
Kather Augenstein is proud to announce that its partner, Dr. Christof Augenstein, has been named to the IAM Strategy 300 – The World’s Leading IP Strategists 2025.
UPC: Jurisdiction for infringement actions against several companies located domestically and abroad (Local Division Munich)
In a decision dated 20 June 2025, the Munich Local Division of the Unified Patent Court (UPC) ruled on several preliminary objections to its international jurisdiction. The decision concerns a cross-border patent infringement action against four different companies.
Handelsblatt / Best Lawyers in Germany 2025 – Kather Augenstein again honored in the categories of intellectual property law and conflict resolution
Handelsblatt, in collaboration with the renowned US specialist publisher Best Lawyers, has published the 17th edition of its annual ranking of leading lawyers in Germany. Kather Augenstein has again been listed in intellectual property and litigation.
On the territorial scope of injunctive relief and the burden of demonstration and proof for the complainant (R. 13m RoP and R. 171.1 RoP), Local Division Paris, decision of 24 April 2025, UPC_CFI_440/2023)
In proceedings concerning an infringement action, the Local Division of Paris had to deal with the question of the claimant’s burden of demonstration and proof with regard to the defendant’s acts of infringement in individual UPC-States.
Twice the Impact: Kather Augenstein Wins Big at the Managing IP EMEA Awards 2025
Kather Augenstein has won two awards at the 20th Managing IP EMEA Awards 2025 in London – the “Impact Case of the Year Europe – Panasonic v OPPO (2024)” and the “Impact Case of the Year Europe – Mammut Sports Group v Ortovox Sportartikel (2024)” – and is thus once again one of the leading law firms in European IP law.
On the requirements of an imminent patent infringement within the meaning of Art. 62 (1) UPCA
Local Division Düsseldorf, decision dated 06 September 2024, UPC_CFI_165/2024, UPC_CFI_166/2024 – Novartis / Genentech
In proceedings concerning the granting of provisional measures, the Local Division Düsseldorf had to deal with the question of when a patent infringement within the meaning of Art. 62 (1) UPCA is “imminent”.
